BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12746265)

  • 1. 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.
    Chin BB; Wahl RL
    Gut; 2003 Jun; 52 Suppl 4(Suppl 4):iv23-9. PubMed ID: 12746265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S56-66. PubMed ID: 12739337
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
    Bourguet P; Planchamp F; Monteil J; Metges JP; Mitry E; Tubiana-Mathieu N
    Bull Cancer; 2007 Feb; 94(2):212-8. PubMed ID: 17338096
    [No Abstract]   [Full Text] [Related]  

  • 4. Staging and follow-up of gastrointestinal tumors with PET/CT.
    Rosenbaum SJ; Stergar H; Antoch G; Veit P; Bockisch A; Kühl H
    Abdom Imaging; 2006; 31(1):25-35. PubMed ID: 16333707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Positron emission tomography in digestive tract cancer].
    Taïeb J; Boige V; Ducreux M; Lumbroso J
    Gastroenterol Clin Biol; 2002 May; 26(5):463-70. PubMed ID: 12122355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies].
    Yun HW; Shim KN
    Korean J Gastroenterol; 2013 Jun; 61(6):303-6. PubMed ID: 23877209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
    Donswijk ML; Hess S; Mulders T; Lam MG
    PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal tract malignancies and positron emission tomography: an overview.
    Esteves FP; Schuster DM; Halkar RK
    Semin Nucl Med; 2006 Apr; 36(2):169-81. PubMed ID: 16517238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in positron emission tomography imaging for the GI tract.
    Pham KH; Ramaswamy MR; Hawkins RA
    Gastrointest Endosc; 2002 Jun; 55(7 Suppl):S53-63. PubMed ID: 12024124
    [No Abstract]   [Full Text] [Related]  

  • 10. PET and PET-CT in esophageal and gastric cancer.
    Wieder HA; Krause BJ; Herrmann K
    Methods Mol Biol; 2011; 727():59-76. PubMed ID: 21331929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma.
    McAteer D; Wallis F; Couper G; Norton M; Welch A; Bruce D; Park K; Nicolson M; Gilbert FJ; Sharp P
    Br J Radiol; 1999 Jun; 72(858):525-9. PubMed ID: 10560332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of 18-F-deoxyglucose (FDG) positron emission tomography (PET) for the diagnosis of pancreatic cancer.
    Buell U; Zimmy M
    World J Surg; 2003 Apr; 27(4):499; author reply 499-500. PubMed ID: 12658505
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastrointestinal malignancies evaluated with (18)F-fluoro-2-deoxyglucose positron emission tomography.
    Chin BB; Chang PP
    Best Pract Res Clin Gastroenterol; 2006 Feb; 20(1):3-21. PubMed ID: 16473798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of positron emission tomography in gastrointestinal imaging.
    Moadel RM; Blaufox MD; Freeman LM
    Gastroenterol Clin North Am; 2002 Sep; 31(3):841-61. PubMed ID: 12481734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
    Chowdhury FU; Bradley KM; Gleeson FV
    Clin Radiol; 2008 Dec; 63(12):1297-309. PubMed ID: 18996259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.
    Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH
    Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using 18F-fluoro-2-deoxyglucose positron emission tomography to detect primary lung cancer in an isolated choroidal metastasis.
    Sève P; Kodjikian L; Vautrin C; Grange JD; Broussolle C
    Arch Ophthalmol; 2004 Oct; 122(10):1548-9. PubMed ID: 15477473
    [No Abstract]   [Full Text] [Related]  

  • 18. False positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography liver lesion mimicking metastasis in 2 patients with gastroesophageal cancer.
    Paudel N; Kunz PL; Poultsides GA; Koong AC; Chang DT
    Pract Radiat Oncol; 2014; 4(6):368-71. PubMed ID: 25407856
    [No Abstract]   [Full Text] [Related]  

  • 19. PET imaging in assessing gastrointestinal tumors.
    Hustinx R
    Radiol Clin North Am; 2004 Nov; 42(6):1123-39, ix. PubMed ID: 15488562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative and laparoscopic ultrasound.
    Kolecki R; Schirmer B
    Surg Clin North Am; 1998 Apr; 78(2):251-71. PubMed ID: 9602846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.